Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Kneat.com Inc T.KSI

Alternate Symbol(s):  KSIOF

Healthcare Medical Devices
kneat.com, inc. develops and markets the Kneat Gx software-as-a-service (SaaS) platform. It designs, develops and supplies software for data and document management within regulated environments. The Company’s focus is to service the facilities, equipment and computer systems (CSV) validation market initially within the global life sciences industry. The Company’s product is Kneat Gx, a... see more

TSX:KSI - Post Discussion

Kneat.com Inc > Polypharma Biologics - new customer
View:
Post by Possibleidiot01 on Jan 05, 2024 8:52pm

Polypharma Biologics - new customer

This appears to be new - their Linkedin posts aren't always consecutive , most recent to older.

Kneat Solutions
 
 
New Customer Announcement

Polpharma Biologics, an international biotechnology company with integrated operations in the European Union, that develops and manufactures biosimilars, has chosen Kneat to digitalize its Computer System Validation process.

Why Kneat Gx?

Most innovative and efficient solution on the market

Best product fit

First class support from Kneat team

If you’re thinking about digitalizing your validation processes in 2024, the Digital Validation Handbook helps you to understand which direction to take. Download your copy today!

https://hubs.li/Q02f4vwN0

#NewCustomer #KneatGx #DigitalTransformation #CSV #SpeedToMarket




Be the first to comment on this post
Kneat.com Inc